Product Description
Clomiphene is an oral agent used to treat infertility in women desiring pregnancy. Clomiphene has been linked to a low rate of transient serum aminotransferase elevations during therapy and to rare instances of clinically apparent liver injury, which can be severe and even fatal. (Sourced from: https://pubchem.ncbi.nlm.nih.gov/compound/Clomifene)
Mechanisms of Action: ER Antagonist
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: *
Approval Status: Approved
Approved Countries: Algeria | Argentina | Australia | Austria | Bangladesh | Belgium | Brazil | Bulgaria | Canada | Chile | Colombia | Cyprus | Czech | Dominican Republic | Ecuador | Egypt | France | Germany | Greece | Hong Kong | Hungary | India | Indonesia | Ireland | Italy | Japan | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | Mexico | Morocco | Netherlands | New Zealand | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Singapore | Slovakia | Slovenia | South Africa | Spain | Sri Lanka | Sweden | Taiwan | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
12/02/2025 |
News Article |
Accord Healthcare Announces Launch of Clomiphene Tablets, a Generic of CLOMID®, for the Treatment of Ovulatory Dysfunction in Women Desiring Pregnancy |
|
11/19/2025 |
News Article |
Polycystic Ovary Syndrome Treatment Market Expected to Reach USD 9.12 Bn by 2034 |
|
08/04/2025 |
News Article |
Fertility Market Size to Reach USD 87.05 Billion by 2034, Driven by 9.06% CAGR |
|
05/02/2025 |
News Article |
The Best SARMS for Cutting, Muscle Growth, Strength & Recovery - User Guide to Buying SARM Stacks for Bulking Cycles, Fat Loss & Shredding - CrazyBulk |